The absence of a unique identifier and tamper‑evident device, together with placing batches on the market without proper certification and release by the Qualified Person, may result in incorrect identification, risk of falsification, or lack of confirmed quality and safety of therapy. Potential effects: lack of efficacy, treatment complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use products from the listed batches. Check the batch number and expiry date on the packaging. If you possess such packs, return them to the pharmacy or wholesaler; if you have any doubts about...
The Chief Pharmaceutical Inspector withdrew from the market Spasmolina 60 mg hard capsules, batch 091016 (expiry 10.2019) and the batches: Spasmolina 60 mg 010119, Andepin 20 mg 010119, Kalium efferve...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ